Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Dhwani Almaula · SciRah

Researcher profile · Semantic Scholar

Dhwani Almaula

Share profile

Dhwani Almaula — researcher profile on SciRah

h-index: 4
Works: 11
Citations: 213

Most-cited papers

Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma.
Nisha S. Joseph, J. Kaufman, M. Dhodapkar, C. Hofmeister +6 more
2020Journal of Clinical Oncology187 citations Open access
Semantic Scholar
Benefits of autologous stem cell transplant for elderly myeloma patients in the last quarter of life.
Nisha S Josepht, Vikas A. Gupta, Sarah Wyman, M. Graiser +8 more
2021Transplantation and Cellular Therapy10 citations Open access
Semantic Scholar
Artificial intelligence for advancing eye care in resource-poor settings: Assessing the predictive accuracy of an AI-model for diabetic retinopathy screening in India
R. Chawla, Prachi Karkhanis, M. Shah, Aritra Das +17 more
2025Global Epidemiology6 citations Open access
Semantic Scholar
Updated survival with extended follow-up on patients with newly diagnosed multiple myeloma treated with lenalidomide, bortezomib, and dexamethasone (RVD) induction therapy and a risk-stratified maintenance approach.
R. Parikh, C. Hofmeister, Dhwani Almaula, L. Heffner +7 more
2022Journal of Clinical Oncology4 citations
Semantic Scholar
RVD is a Superior Induction Regimen Compared to VCD Among Transplant-Eligible Myeloma Patients
A. Nooka, V. Jimenez-Zepeda, L. Boise, J. Kaufman +3 more
20173 citations
Semantic Scholar
Clinical Characteristics and Outcomes of Myeloma Patients Exhibiting Translocation (14;16): An Ultra-High-Risk Group of Myeloma Patients
A. Nooka, E. Kastritis, J. Kaufman, M. Gavriatopoulou +7 more
20171 citations
Semantic Scholar
Lenalidomide, Bortezomib, and Dexamethasone (RVD) As Induction Therapy in Newly Diagnosed Multiple Myeloma (MM)
Nisha S. Joseph, Dhwani Almaula, C. Gleason, L. Heffner +4 more
20171 citations
Semantic Scholar
Patterns of Relapse Among Myeloma Patients Post-Autologous Stem Cell Transplant
P. Kumar, Nisha S. Joseph, Dhwani Almaula, L. Boise +4 more
20161 citations
Semantic Scholar
32 Laboratory Evaluation for Therapy-Related Myeloid Neoplasia-Associated Changes After Autotransplant for Multiple Myeloma
Tesha Guillory, Dhwani Almaula, D. Saxe, A. Nooka +1 more
20180 citations Open access
Semantic Scholar
Safety and Engraftment Parameters for Bloodless Transplants among Myeloma Patients
Nisha S. Joseph, J. Kaufman, L. Boise, Dhwani Almaula +6 more
20170 citations
Semantic Scholar
Survival Outcomes of Younger (≤ 50 years) Myeloma Patients
Dhwani Almaula, Nisha S. Joseph, J. Kaufman, L. Heffner +5 more
20170 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Nooka×10
Invite
A. Nooka — researcher profile on SciRah
J. Kaufman×9
Invite
J. Kaufman — researcher profile on SciRah
S. Lonial×9
Invite
S. Lonial — researcher profile on SciRah
L. Boise×8
Invite
L. Boise — researcher profile on SciRah

Nisha S. Joseph

×6

Invite

Nisha S. Joseph — researcher profile on SciRah

Invite

L. Heffner — researcher profile on SciRah

M. Dhodapkar×3

Invite

M. Dhodapkar — researcher profile on SciRah

C. Hofmeister×3

Invite

C. Hofmeister — researcher profile on SciRah

Vikas A. Gupta×3

Invite

Vikas A. Gupta — researcher profile on SciRah

Invite

D. Jaye — researcher profile on SciRah

Invite

C. Gleason — researcher profile on SciRah

Nisha S Josepht×1

Invite

Nisha S Josepht — researcher profile on SciRah